Transfusion in critically ill children: Indications, risks, and challenges

Critical Care Medicine

Volumn 42, Issue 3, 2014, Pages 675-690

  Parker, Robert I ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b Renaissance School of Medicine at Stony Brook University   (United States)

Author keywords

clotting factor concentrates; pediatrics; plasma; platelets; red blood cells; transfusion

Indexed keywords

BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CRITICAL CARE; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL MORTALITY; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PLASMA; PLATELET TRANSFUSION; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84894443816     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000176     Document Type: Review

References (184)

1. Carson JL, Grossman BJ, Kleinman S, et al; Clinical Transfusion Medicine Committee of the AABB: Red blood cell transfusion: A clinical practice guideline from the AABB. Ann Intern Med 2012; 157:49-58
2. Zou S, Dorsey KA, Notari EP, et al: Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50:1495-1504
3. Zou S, Stramer SL, Notari EP, et al: Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009; 49:1609-1620
4. Toy P, Gajic O, Bacchetti P, et al; TRALI Study Group: Transfusion- related acute lung injury: Incidence and risk factors. Blood 2012; 119:1757-1767
5. Sayah DM, Looney MR, Toy P: Transfusion reactions: Newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury. Crit Care Clin 2012; 28:363- 372, v
6. Gauvin F, Robillard P, Hume H, et al: Transfusion-related acute lung injury in the Canadian paediatric population. Paediatr Child Health 2012; 17:235-239
7. Li G, Rachmale S, Kojicic M, et al: Incidence and transfusion risk factors for transfusion-Associated circulatory overload among medical intensive care unit patients. Transfusion 2011; 51:338-343
8. Murphy EL, Kwaan N, Looney MR, et al; TRALI Study Group: Risk factors and outcomes in transfusion-Associated circulatory overload. Am J Med 2013; 126:357.e29-357.e38
9. Miller ST, Kim HY, Weiner DL, et al; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN): Red blood cell alloimmunization in sickle cell disease: Prevalence in 2010. Transfusion 2013; 53:704-709
10. OSuoji C, Liem RI, Mack AK, et al: Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer 2013; 60:1487-1491
11. Vichinsky E, Neumayr L, Trimble S, et al; CDC Thalassemia Investigators: Transfusion complications in thalassemia patients: A report from the Centers for Disease Control and Prevention. Transfusion 2013 Jul 25 [Epub ahead of print]
12. Sihler KC, Napolitano LM: Complications of massive transfusion. Chest 2010; 137:209-220
13. Diaz J, Acosta F, Parrilla P, et al: Citrate intoxication and blood concentration of ionized calcium in liver transplantation. Transplant Proc 1994; 26:3669-3670
14. Marlow SD, House M: Managing apheresis complications during the hematopoietic stem cell collection. Methods Mol Biol 2012; 904:93-96
15. Bihl F, Castelli D, Marincola F, et al: Transfusion-transmitted infections. J Transl Med 2007; 5:25
16. Abrol P, Lal H: Transfusion-transmitted bacterial, viral and protozoal infections. In: Blood Transfusion in Clinical Practice. Kochhar P (Ed). Ninth Edition. Rijeka, Croatia, 2012, pp 143-154
17. Perez P, Salmi LR, Folla G, et al; BACTHEM Group; French Haemovigilance Network: Determinants of transfusion-Associated bacterial contamination: Results of the French BACTHEM Case- Control Study. Transfusion 2001; 41:862-872
18. Williamson LM, Lowe S, Love EM, et al: Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports. BMJ 1999; 319:16-19
19. Kuehnert MJ, Roth VR, Haley NR, et al: Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41:1493-1499
20. Blajchman MA, Goldman M: Bacterial contamination of platelet concentrates: Incidence, significance, and prevention. Semin Hematol 2001; 38:20-26
21. Wagner SJ: Transfusion-transmitted bacterial infection: Risks, sources and interventions. Vox Sang 2004; 86:157-163
22. Eder AF, Kennedy JM, Dy BA, et al; American Red Cross Regional Blood Centers: Limiting and detecting bacterial contamination of apheresis platelets: Inlet-line diversion and increased culture volume improve component safety. Transfusion 2009; 49:1554-1563
23. Nichols WG, Price TH, Gooley T, et al: Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003; 101:4195-4200
24. Vamvakas EC: Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-Analysis. Transfus Med Rev 2005; 19:181-199
25. Luban NL, McBride E, Ford JC, et al: Transfusion medicine problems and solutions for the pediatric hematologist/oncologist. Pediatr Blood Cancer 2012; 58:1106-1111
26. Zou S, Stramer SL, Dodd RY: Donor testing and risk: Current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev 2012; 26:119-128
27. Attaullah S, Khan S, Khan J: Trend of transfusion transmitted infections frequency in blood donors: Provide a road map for its prevention and control. J Transl Med 2012; 10:20
28. Batista-dos-Santos S, Raiol M, Santos S, et al: Real-time PCR diagnosis of Plasmodium vivax among blood donors. Malar J 2012; 11:345
29. Sobral PM, Barros AE, Gomes AM, et al: Viral inactivation in hemotherapy: Systematic review on inactivators with action on nucleic acids. Rev Bras Hematol Hemoter 2012; 34:231-235
30. Tissot JD, Rubin O, Canellini G: Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010; 17:571-577
31. Strobel E: Hemolytic transfusion reactions. Transfus Med Hemother 2008; 35:346-353
32. Lavoie J: Blood transfusion risks and alternative strategies in pediatric patients. Paediatr Anaesth 2011; 21:14-24
33. Pandey S, Vyas GN: Adverse effects of plasma transfusion. Transfusion 2012; 52(Suppl 1):65S-79S
34. Bersus O, Boman K, Nessen SC, et al: Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion 2013; 53(Suppl 1):114S-123S
35. Kleinman S, Chan P, Robillard P: Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003; 17:120-162
36. Dunbar NM, Ornstein DL, Dumont LJ: ABO incompatible platelets: Risks versus benefit. Curr Opin Hematol 2012; 19:475-479
37. Karafin MS, Blagg L, Tobian AA, et al: ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion 2012; 52:2087-2093
38. Heddle NM: Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol 1999; 6:420-426
39. King KE, Shirey RS, Thoman SK, et al: Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004; 44:25-29
40. Paglino JC, Pomper GJ, Fisch GS, et al: Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004; 44:16-24
41. Wang RR, Triulzi DJ, Qu L: Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets. Am J Clin Pathol 2012; 138:255-259
42. Hirayama F: Current understanding of allergic transfusion reactions: Incidence, pathogenesis, laboratory tests, prevention and treatment. Br J Haematol 2013; 160:434-444
43. Gilstad CW: Anaphylactic transfusion reactions. Curr Opin Hematol 2003; 10:419-423
44. Sandler SG, Mallory D, Malamut D, et al: IgA anaphylactic transfusion reactions. Transfus Med Rev 1995; 9:1-8
45. Vassallo RR: Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products. Immunohematology 2004; 20:226-233
46. Chapman CE, Stainsby D, Jones H, et al; Serious Hazards of Transfusion Steering Group: Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49:440-452
47. Wiersum-Osselton JC, Middelburg RA, Beckers EA, et al: Male-only fresh-frozen plasma for transfusion-related acute lung injury prevention: Before-And-After comparative cohort study. Transfusion 2011; 51:1278-1283
48. Eder AF, Dy BA, Perez JM, et al: The residual risk of transfusion- related acute lung injury at the American Red Cross (2008-2011): Limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013; 53:1442-1449
49. Pavenski K, Saidenberg E, Lavoie M, et al: Red blood cell storage lesions and related transfusion issues: A Canadian Blood Services research and development symposium. Transfus Med Rev 2012; 26:68-84
50. Doctor A, Spinella P: Effect of processing and storage on red blood cell function in vivo. Semin Perinatol 2012; 36:248-259
51. Donadee C, Raat NJ, Kanias T, et al: Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124:465-476
52. Roback JD: Vascular effects of the red blood cell storage lesion. Hematology Am Soc Hematol Educ Program 2011; 2011:475-479
53. Kim-Shapiro DB, Lee J, Gladwin MT: Storage lesion: Role of red blood cell breakdown. Transfusion 2011; 51:844-851
54. Weinberg JA, MacLennan PA, Vandromme-Cusick MJ, et al: Microvascular response to red blood cell transfusion in trauma patients. Shock 2012; 37:276-281
55. Alexander JT, El-Ali AN, Newman JL, et al: Red blood cells stored for increasing periods produce progressive impairments in nitric oxide- mediated vasodilation. Transfusion 2013; 53:2619-2628
56. Tinmouth A, Fergusson D, Yee IC, et al; ABLE Investigators; Canadian Critical Care Trials Group: Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46:2014-2027
57. Lelubre C, Vincent JL: Relationship between red cell storage duration and outcomes in adults receiving red cell transfusions: A systematic review. Crit Care 2013; 17:R66
58. Fergusson DA, Hbert P, Hogan DL, et al: Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: The ARIPI randomized trial. JAMA 2012; 308:1443-1451
59. Weinberg JA, McGwin G Jr, Vandromme MJ, et al: Duration of red cell storage influences mortality after trauma. J Trauma 2010; 69:1427-1431
60. Spinella PC, Carroll CL, Staff I, et al: Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries. Crit Care 2009; 13:R151
61. Katsios C, Griffith L, Spinella P, et al: Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: A prospective observational cohort study. Crit Care 2011; 15:R263
62. Cywinski JB, You J, Argalious M, et al: Transfusion of older red blood cells is associated with decreased graft survival after orthotopic liver transplantation. Liver Transpl 2013; 19:1181-1188
63. Horvath KA, Acker MA, Chang H, et al: Blood transfusion and infection after cardiac surgery. Ann Thorac Surg 2013; 95:2194-2201
64. Purohit S, Alvarez O, OBrien R, et al: Durable immune response to inactivated H1N1 vaccine is less likely in children with sickle cell anemia receiving chronic transfusions. Pediatr Blood Cancer 2012; 59:1280-1283
65. Yazdanbakhsh K, Bao W, Zhong H: Immunoregulatory effects of stored red blood cells. Hematology Am Soc Hematol Educ Program 2011; 2011:466-469
66. Neal MD, Raval JS, Triulzi DJ, et al: Innate immune activation after transfusion of stored red blood cells. Transfus Med Rev 2013; 27:113-118
67. Howard-Quijano K, Schwarzenberger JC, Scovotti JC, et al: Increased red blood cell transfusions are associated with worsening outcomes in pediatric heart transplant patients. Anesth Analg 2013; 116:1295-1308
68. Muszynski J, Nateri J, Nicol K, et al: Immunosuppressive effects of red blood cells on monocytes are related to both storage time and storage solution. Transfusion 2012; 52:794-802
69. Hill GE, Frawley WH, Griffith KE, et al: Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta- analysis. J Trauma 2003; 54:908-914
70. Hbert PC, Fergusson D, Blajchman MA, et al; Leukoreduction Study Investigators: Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289:1941-1949
71. Friese RS, Sperry JL, Phelan HA, et al: The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients. Am J Surg 2008; 196:56-61
72. Phelan HA, Eastman AL, Aldy K, et al: Prestorage leukoreduction abrogates the detrimental effect of aging on packed red cells transfused after trauma: A prospective cohort study. Am J Surg 2012; 203:198-204
73. Benson AB, Burton JR Jr, Austin GL, et al: Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl 2011; 17:149-158
74. Hod EA, Zhang N, Sokol SA, et al: Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010; 115:4284-4292
75. Hod EA, Spitalnik SL: Stored red blood cell transfusions: Iron, inflammation, immunity, and infection. Transfus Clin Biol 2012; 19:84-89
76. Ozment CP, Mamo LB, Campbell ML, et al: Transfusion-related biologic effects and free hemoglobin, heme, and iron. Transfusion 2013; 53:732-740
77. Aubron C, Nichol A, Cooper DJ, et al: Age of red blood cells and transfusion in critically ill patients. Ann Intensive Care 2013; 3:2
78. Juffermans NP, Vlaar AP, Prins DJ, et al: The age of red blood cells is associated with bacterial infections in critically ill trauma patients. Blood Transfus 2012; 10:290-295
79. Manlhiot C, McCrindle BW, Menjak IB, et al: Longer blood storage is associated with suboptimal outcomes in high-risk pediatric cardiac surgery. Ann Thorac Surg 2012; 93:1563-1569
80. Inaba K, Branco BC, Rhee P, et al: Impact of the duration of platelet storage in critically ill trauma patients. J Trauma 2011; 71:1766-1773
81. Karam O, Tucci M, Bateman ST, et al: Association between length of storage of red blood cell units and outcome of critically ill children: A prospective observational study. Crit Care 2010; 14:R57
82. Gauvin F, Spinella PC, Lacroix J, et al; Canadian Critical Care Trials Group and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Association between length of storage of transfused red blood cells and multiple organ dysfunction syndrome in pediatric intensive care patients. Transfusion 2010; 50: 1902-1913
83. Whitaker BI, Schlumpf K, Schulman J, et al: Report of the US Department of Health and Human Services. The 2009 National Blood Collection and Utilization Survey Report. Washington, DC, US Department of Health and Human Services, Office of the Assistant Secretary for Health, 2011
84. Josephson, C: Neonatal and pediatric transfusion practice. In: AABB Technical Manual. Roback JD (Ed). 17th Edition. Bethesda, MD, AABB, 2011, pp 645-760
85. Istaphanous GK, Wheeler DS, Lisco SJ, et al: Red blood cell transfusion in critically ill children: A narrative review. Pediatr Crit Care Med 2011; 12:174-183
86. Sloniewsky D: Anemia and transfusion in critically ill pediatric patients: A review of etiology, management, and outcomes. Crit Care Clin 2013; 29:301-317
87. Hbert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417
88. Kirpalani H, Whyte RK, Andersen C, et al: The Premature Infants in Need of Transfusion (PINT) study: A randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006; 149:301-307
89. LacroixJ, Hepert PC, Hutchison JS, et al: Transfusion strategies for patients in pediatric intensive care units. TRIPICU Investigators, the Canadian Critical Care Trials Group, and the Pediatric Acute Lung Injury and Sepsis Investigators Network. N Engl J Med 2007; 356:1609-1619
90. Carson JL, Carless PA, Hebert PC: Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4:CD002042
91. Villanueva C, Colomo A, Bosch A, et al: Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368:11-21
92. Rouette J, Trottier H, Ducruet T, et al; Canadian Critical Care Trials Group; PALISI Network: Red blood cell transfusion threshold in postsurgical pediatric intensive care patients: A randomized clinical trial. Ann Surg 2010; 251:421-427
93. Willems A, Harrington K, Lacroix J, et al; TRIPICU investigators; Canadian Critical Care Trials Group; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: A subgroup analysis. Crit Care Med 2010; 38:649-656
94. Cholette JM, Rubenstein JS, Alfieris GM, et al: Children with single- ventricle physiology do not benefit from higher hemoglobin levels post cavopulmonary connection: Results of a prospective, randomized, controlled trial of a restrictive versus liberal red-cell transfusion strategy. Pediatr Crit Care Med 2011; 12:39-45
95. de Gast-Bakker DH, de Wilde RB, Hazekamp MG, et al: Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: A randomized controlled trial. Intensive Care Med 2013; 39:2011-2019
96. Karam O, Tucci M, Ducruet T, et al; Canadian Critical Care Trials Group; PALISI Network: Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med 2011; 12:512-518
97. Guzzetta NA: Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery. Paediatr Anaesth 2011; 21:504-511
98. Kneyber MC, Grotenhuis F, Berger RF, et al: Transfusion of leukocyte- depleted RBCs is independently associated with increased morbidity after pediatric cardiac surgery. Pediatr Crit Care Med 2013; 14:298-305
99. Lacroix J: Red cell transfusion: Risk marker or risk factor in cardiac children? Pediatr Crit Care Med 2013; 14:330-331
100. Valieva OA, Strandjord TP, Mayock DE, et al: Effects of transfusions in extremely low birth weight infants: A retrospective study. J Pediatr 2009; 155:331-337.e1
101. Christensen RD, Del Vecchio A, Ilstrup SJ: More clearly defining the risks of erythrocyte transfusion in the NICU. J Matern Fetal Neonatal Med 2012; 25:90-92
102. Whyte R, Kirpalani H: Low versus high hemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev 2011; 11:CDC000512
103. Christensen RD: Associations between early red blood cell transfusion and severe intraventricular hemorrhage, and between late red blood cell transfusion and necrotizing enterocolitis. Semin Perinatol 2012; 36:283-289
104. Paul DA, Mackley A, Novitsky A, et al: Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants. Pediatrics 2011; 127:635-641
105. Demirel G, Celik IH, Aksoy HT, et al: Transfusion-Associated necrotising enterocolitis in very low birth weight premature infants. Transfus Med 2012; 22:332-337
106. Bak SY, Lee S, Park JH, et al: Analysis of the association between necrotizing enterocolitis and transfusion of red blood cell in very low birth weight preterm infants. Korean J Pediatr 2013; 56: 112-115
107. McCoy TE, Conrad AL, Richman LC, et al: Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol 2011; 17:347-367
108. Whyte RK: Neurodevelopmental outcome of extremely low- birth-weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Semin Perinatol 2012; 36:290-293
109. Spinella PC, Dressler A, Tucci M, et al; Pediatric Acute Lung Injury and Sepsis Investigators Network: Survey of transfusion policies at US and Canadian childrens hospitals in 2008 and 2009. Transfusion 2010; 50:2328-2335
110. Leal-Noval SR, Arellano-Orden V, Maestre-Romero A, et al: Impact of national transfusion indicators on appropriate blood usage in critically ill patients. Transfusion 2011; 51:1957-1965
111. Guilln U, Cummings JJ, Bell EF, et al: International survey of transfusion practices for extremely premature infants. Semin Perinatol 2012; 36:244-247
112. Dallman MD, Liu X, Harris AD, et al: Changes in transfusion practice over time in the PICU. Pediatr Crit Care Med 2013; 14:843-850
113. Murphy DJ, Needham DM, Netzer G, et al: RBC transfusion practices among critically ill patients: Has evidence changed practice? Crit Care Med 2013; 41:2344-2353
114. Wong EC, Perez-Albuerne E, Moscow JA, et al: Transfusion management strategies: A survey of practicing pediatric hematology/ oncology specialists. Pediatr Blood Cancer 2005; 44:119-127
115. Bercovitz RS, Quinones RR: A survey of transfusion practices in pediatric hematopoietic stem cell transplant patients. J Pediatr Hematol Oncol 2013; 35:e60-e63
116. Muntean W: Fresh frozen plasma in the pediatric age group and in congenital coagulation factor deficiency. Thromb Res 2002; 107(Suppl 1):S29-S32
117. Goldenberg NA, Manco-Johnson MJ: Pediatric hemostasis and use of plasma components. Best Pract Res Clin Haematol 2006; 19:143-155
118. Karam O, Lacroix J, Robitaille N, et al: Association between plasma transfusion and clinical outcome in critically ill children: A prospective observational study. Vox Sang 2013; 104:1-8
119. Puetz J, Witmer C, Huang YS, et al: Widespread use of fresh frozen plasma in US childrens hospitals despite limited evidence demonstrating a beneficial effect. J Pediatr 2012; 160:210-215.e1
120. Motta M, Del Vecchio A, Radicioni M: Clinical use of fresh- frozen plasma and cryoprecipitate in neonatal intensive care unit. J Matern Fetal Neonatal Med 2011; 24(Suppl 1):129-131
121. Gajic O, Dzik WH, Toy P: Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: Benefit or harm? Crit Care Med 2006; 34:S170-S173
122. Verghese SG: Elective fresh frozen plasma in the critically ill: What is the evidence? Crit Care Resusc 2008; 10:264-268
123. Stanworth SJ: The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program 2007; 179-186
124. Stanworth SJ, Brunskill SJ, Hyde CJ, et al: Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126:139-152
125. Dara SI, Rana R, Afessa B, et al: Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 2005; 33:2667-2671
126. Abdel-Wahab OI, Healy B, Dzik WH: Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46:1279-1285
127. Chowdhury P, Saayman AG, Paulus U, et al: Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125:69-73
128. Segal JB, Dzik WH; Transfusion Medicine/Hemostasis Clinical Trials Network: Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: An evidence-based review. Transfusion 2005; 45:1413-1425
129. Keeling D: International normalized ratio in patients not on vitamin K antagonists. J Thromb Haemost 2007; 5:188-189
130. Roback JD, Caldwell S, Carson J, et al; American Association for the Study of Liver; American Academy of Pediatrics; United States Army; American Society of Anesthesiology; American Society of Hematology: Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50:1227-1239
131. Stanworth SJ, Walsh TS, Prescott RJ, et al; Intensive Care Study of Coagulopathy (ISOC) Investigators: A national study of plasma use in critical care: Clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15:R108
132. Flesland O: A comparison of complication rates based on published haemovigilance data. Intensive Care Med 2007; 33(Suppl 1):S17-21
133. Goodnough LT: A reappraisal of plasma, prothrombin complex concentrates, and recombinant factor VIIa in patient blood management. Crit Care Clin 2012; 28:413-426
134. Simpson E, Lin Y, Stanworth S, et al: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrne Database Syst Rev 2012; 3:CDC005011
135. Kozek-Langenecker S, Srensen B, Hess JR, et al: Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: A systematic review. Crit Care 2011; 15:R239
136. Warmuth M, Mad P, Wild C: Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 2012; 56:539-548
137. Bercovitz RS, Josephson CD: Thrombocytopenia and bleeding in pediatric oncology patients. Hematology Am Soc Hematol Educ Program 2012; 2012:499-505
138. Freireich TJ, Klimann A, Gaydos LA, et al: Response to repeated platelet transfusions from the same donor. Ann Intern Med 1963; 59:277-87
139. Djerassi I, Farber S, Evans AE: Transfusions of fresh platelet concentrates to patients with secondary thrombocytopenia. N Engl J Med 1963; 268:221-226
140. Gaydos LA, Freireich EJ, Mantel N: The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962; 266:905-909
141. Roy AJ, Jaffe N, Djerassi I: Prophylactic platelet transfusions in children with acute leukemia: A dose response study. Transfusion 1973; 13:283-290
142. Heddle NM, Cook RJ, Tinmouth A, et al; SToP Study Investigators of the BEST Collaborative: A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood 2009; 113:1564-1573
143. Slichter SJ, Kaufman RM, Assmann SF, et al: Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362:600-613
144. Schiffer CA, Anderson KC, Bennett CL, et al; American Society of Clinical Oncology: Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19:1519-1538
145. British Committee for Standards in Hematology, Blood Transfusion Task Force: Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10-23
146. Razzaghi A, Barkun AN: Platelet transfusion threshold in patients with upper gastrointestinal bleeding: A systematic review. J Clin Gastroenterol 2012; 46:482-486
147. Zeidler K, Arn K, Senn O, et al: Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion 2011; 51:2269-2276
148. Josephson CD, Granger S, Assmann SF, et al: Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia. Blood 2012; 120:748-760
149. Estcourt L, Stanworth S, Doree C, et al: Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2012; 5:CD004269
150. Wandt H, Schaefer-Eckart K, Wendelin K, et al; Study Alliance Leukemia: Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: An open- label, multicentre, randomised study. Lancet 2012; 380:1309-1316
151. Stanworth SJ, Estcourt LJ, Powter G, et al; TOPPS Investigators: A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013; 368:1771-1780
152. Estcourt LJ, Birchall J, Lowe D, et al: Platelet transfusions in haematology patients: Are we using them appropriately? Vox Sang 2012; 103:284-293
153. Del Vecchio A, Motta M: Evidence-based platelet transfusion recommendations in neonates. J Matern Fetal Neonatal Med 2011; 24(Suppl 1):38-40
154. Stanworth SJ: Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates. Hematology Am Soc Hematol Educ Program 2012; 2012:512-516
155. Andrew M, Vegh P, Caco C, et al: A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123:285-291
156. Josephson CD, Su LL, Christensen RD, et al: Platelet transfusion practices among neonatologists in the United States and Canada: Results of a survey. Pediatrics 2009; 123:278-285
157. Dohner ML, Wiedmeier SE, Stoddard RA, et al: Very high users of platelet transfusions in the neonatal intensive care unit. Transfusion 2009; 49:869-872
158. Cremer M, Sola-Visner M, Roll S, et al: Platelet transfusions in neonates: Practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 2011; 51:2634-2641
159. Slichter SJ: Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program 2007:172-178
160. Massey E, Paulus U, Doree C, et al: Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev 2009; 1:005341
161. Strauss RG: Role of granulocyte/neutrophil transfusions for haematology/ oncology patients in the modern era. Br J Haematol 2012; 158:299-306
162. Seidel MG, Minkov M, Witt V, et al: Granulocyte transfusions in children and young adults: Does the dose matter? J Pediatr Hematol Oncol 2009; 31:166-172
163. Ofan Y, Aviv I, Oliven A, et al: Granulocyte transfusions for neutropenic patients following life-threatening infections: A single centre experience in 47 patients, who received 348 granulocyte transfusions. Vox Sang 2007; 93:363-369
164. Cherif H, Axdorph U, Kalin M, et al: Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection. Scand J Infect Dis 2013; 45:112-116
165. Pammi M, Brocklehurst P: Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database Syst Rev 2011; 10:CDC003956
166. Diab YA, Wong EC, Luban NL: Massive transfusion in children and neonates. Br J Haematol 2013; 161:15-26
167. Spinella PC, Holcomb JB: Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009; 23: 231-240
168. Ledgerwood AM, Blaisdell W: Coagulation challenges after severe injury with hemorrhagic shock. J Trauma Acute Care Surg 2012; 72:1714-1718
169. Reed RL 2nd, Ciavarella D, Heimbach DM, et al: Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study. Ann Surg 1986; 203:40-48
170. Holcomb JB, del Junco DJ, Fox EE, et al; PROMMTT Study Group: The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a timevarying treatment with competing risks. JAMA Surg 2013; 148: 127-136
171. Hallet J, Lauzier F, Mailloux O, et al: The use of higher platelet: RBC transfusion ratio in the acute phase of trauma resuscitation: A systematic review. Crit Care Med 2013; 41:2800-2811
172. Brown RE, Dorion RP, Trowbridge C, et al: Algorithmic and consultative integration of transfusion medicine and coagulation: A personalized medicine approach with reduced blood component utilization. Ann Clin Lab Sci 2011; 41:211-216
173. Khan S, Allard S, Weaver A, et al: A major haemorrhage protocol improves the delivery of blood component therapy and reduces waste in trauma massive transfusion. Injury 2013; 44:587-592
174. Chidester SJ, Williams N, Wang W, et al: A pediatric massive transfusion protocol. J Trauma Acute Care Surg 2012; 73:1273-1277
175. Hendrickson JE, Shaz BH, Pereira G, et al: Implementation of a pediatric trauma massive transfusion protocol: One institutions experience. Transfusion 2012; 52:1228-1236
176. Tasaki T, Ohto H, Sasaki S, et al: Significance of pre-storage leucoreduction for autologous blood. Vox Sang 2009; 96:226-233
177. Fast LD: Developments in the prevention of transfusion- associated graft-versus-host disease. Br J Haematol 2012; 158:563-568
178. Valeri CR, Pivacek LE, Gray AD, et al: The safety and therapeutic effectiveness of human red cells stored at -80 degrees C for as long as 21 years. Transfusion 1989; 29:429-437
179. Henkelman S, Lagerberg JW, Graaff R, et al: The effects of cryopreservation on red blood cell rheologic properties. Transfusion 2010; 50:2393-2401
180. Tobian AA, Savage WJ, Tisch DJ, et al: Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011; 51:1676-1683
181. Vraets A, Lin Y, Callum JL: Transfusion-Associated hyperkalemia. Transfus Med Rev 2011; 25:184-196
182. Waters JH, Tuohy MJ, Hobson DF, et al: Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology 2003; 99:652-655
183. Cholette JM, Henrichs KF, Alfieris GM, et al: Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: Results of a prospective, randomized, controlled clinical trial. Pediatr Crit Care Med 2012; 13:290-299
184. Cholette JM, Powers KS, Alfieris GM, et al: Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: Results of a prospective, randomized, clinical trial. Pediatr Crit Care Med 2013; 14:137-147